{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:47:03Z","timestamp":1789940823894,"version":"4.0.1"},"reference-count":36,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Addressing the challenges of ambulatory surgery involves balancing effective pain relief with minimizing the side effects of pain medication. Due to the heightened risk of opioid abuse, Helsinki University Hospital (Finland) has had a stringent oxycodone prescription policy. This policy prompts an exploration into whether ambulatory surgery patients experience severe post-surgical pain and whether an increase in prescribed opioids would cause elevation in adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective cohort study, with a 1-week follow-up, included 111 adult ambulatory surgery patients (orthopaedics, urology). The patients documented their pain levels within the first postoperative week (using a numerical rating scale [NRS] of 0\u201310) and pain medication intake up to two days postoperatively. Furthermore, they completed a questionnaire assessing their satisfaction with pain relief, medication-related adverse effects, and adherence to instructions. Medication intake was cross-referenced with the provided instructions and prescriptions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A notable 56% of patients reported experiencing intense pain (NRS \u22655) within a week following surgery. Of these, 52% received a single dose of slow-release oxycodone (5\u201320\u2009mg) at discharge for use on the night of surgery. Predominantly prescribed pain medications included a combination of paracetamol and codeine (64%) or ibuprofen (62%). Satisfaction rates were high, with 87% expressing satisfaction with pain medication given at hospital discharge and 90% expressing contentment with the prescribed medication. The most common adverse effects were tiredness\/grogginess (45%), sleep disturbances (38%), nausea (37%), and constipation (27%). Also, 24% of patients self-reported deviations from medication instructions. A comparison of self-reported and instructed medications revealed that 14% exceeded prescribed dosages, and 28% opted for preparations different from those prescribed. Notably, patients who self-reported deviations from instructions differed from those objectively deviating from instructions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although 56% of patients had intense pain, the majority expressed satisfaction with the provided pain relief. Instances of non-adherence to medication instructions were prevalent, often going unnoticed by the patients themselves.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/sjpain-2023-0133","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T12:20:46Z","timestamp":1717676446000},"source":"Crossref","is-referenced-by-count":6,"title":["Patient-reported pain, satisfaction, adverse effects, and deviations from ambulatory surgery pain medication"],"prefix":"10.1515","volume":"24","author":[{"given":"Iiris","family":"S\u00e4rkilahti","sequence":"first","affiliation":[{"name":"Helsinki University Hospital and University of Helsinki, Perioperative and Intensive Care, Peijas Hospital , PO Box 900 (Sairaalakatu 1), FI-00029 HUS , Vantaa , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Reponen","sequence":"additional","affiliation":[{"name":"Helsinki University Hospital and University of Helsinki, Perioperative and Intensive Care, Peijas Hospital , PO Box 900 (Sairaalakatu 1), FI-00029 HUS , Vantaa , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noora","family":"Skants","sequence":"additional","affiliation":[{"name":"Helsinki University Hospital and University of Helsinki, Perioperative and Intensive Care, Peijas Hospital , PO Box 900 (Sairaalakatu 1), FI-00029 HUS , Vantaa , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"key":"2025120910063046202_j_sjpain-2023-0133_ref_001","doi-asserted-by":"crossref","unstructured":"Majholm B, Engb\u00e6k J, Bartholdy J, Oerding H, Ahlburg P, Ulrik AMG, et al. Is day surgery safe? A Danish multicentre study of morbidity after 57, 709 day surgery procedures. Acta Anaesthesiol Scand. 2012;56: 323\u201331.","DOI":"10.1111\/j.1399-6576.2011.02631.x"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_002","doi-asserted-by":"crossref","unstructured":"Qin C, Dekker RG, Blough JT, Kadakia AR. Safety and outcomes of inpatient compared with outpatient surgical procedures for ankle fractures. J Bone Jt Surg Am. 2016;98:1699\u2013705.","DOI":"10.2106\/JBJS.15.01465"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_003","doi-asserted-by":"crossref","unstructured":"Bryson GL, Mercer C, Varpio L. Patient and caregiver experience following ambulatory surgery: qualitative analysis in a cohort of patients 65 yr and older. Can J Anesth. 2014; 61:986\u201394.","DOI":"10.1007\/s12630-014-0229-3"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_004","doi-asserted-by":"crossref","unstructured":"Chaudier P, Bourdin M, Gauthier J, Fessy MH, Besse JL. Similar levels of pain are reported in forefoot surgery after management as a day case and admission for 48 hours: a continuous prospective study of 317 patients. Bone Jt J. 2015;97-B:1645\u201350.","DOI":"10.1302\/0301-620X.97B12.35608"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_005","doi-asserted-by":"crossref","unstructured":"Hill MV, McMahon ML, Stucke RS, Barth Jr RJ. Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg. 2017;265:709\u201314.","DOI":"10.1097\/SLA.0000000000001993"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_006","doi-asserted-by":"crossref","unstructured":"Kumar K, Gulotta LV, Dines JS, Allen AA, Cheng J, Fields KG, et al. Unused opioid pills after outpatient shoulder surgeries given current perioperative prescribing habits. Am J Sports Med. 2017;45:636\u201341.","DOI":"10.1177\/0363546517693665"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_007","unstructured":"Drug Enforcement Administration. National Drug Threat Assessment 2020; March 2021. https:\/\/www.dea.gov\/sites\/default\/files\/2021-02\/DIR-008-21%202020%20National%20Drug%20Threat%20Assessment_WEB.pdf. Accessed Feb 26, 2024"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_008","doi-asserted-by":"crossref","unstructured":"Scully RE, Nguyen LL. Defining postoperative opioid needs among preoperative opioid users\u2014reply. JAMA Surg 2018;153:689\u201390.","DOI":"10.1001\/jamasurg.2018.0218"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_009","doi-asserted-by":"crossref","unstructured":"Wu CL, Berenholtz SM, Pronovost PJ, Fleisher LA. Systematic review and analysis of postdischarge symptoms after outpatient surgery. Anesthesiology. 2002;96:994\u20131003.","DOI":"10.1097\/00000542-200204000-00030"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_010","doi-asserted-by":"crossref","unstructured":"Rawal N. Analgesia for day-case surgery. Br J Anaesth 2001;87:73\u201387.","DOI":"10.1093\/bja\/87.1.73"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_011","doi-asserted-by":"crossref","unstructured":"van der Worp F, Stapel JT, Lako S, Hendriks J, Vissers KCP, Steegers MAH. The comparison of two analgesic regimes after ambulatory surgery: an observational study. Pain Pract. 2014;14:260\u201370.","DOI":"10.1111\/papr.12068"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_012","doi-asserted-by":"crossref","unstructured":"Crockett SD, Greer KB, Heidelbaugh JJ, Falck-Ytter Y, Hanson BJ, Sultan S, et al. American Gastroenterological Association Institute Guideline on the medical management of opioid-induced constipation. Gastroenterology. 2019;156:218\u201326.","DOI":"10.1053\/j.gastro.2018.07.016"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_013","doi-asserted-by":"crossref","unstructured":"Goettsch WG, Sukel MPP, van der Peet DL, van Riemsdijk MM, Herings RMC. In-hospital use of opioids increases rate of coded postoperative paralytic ileus. Pharmacoepidemiol Drug Saf. 2007;16:668\u201374.","DOI":"10.1002\/pds.1338"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_014","doi-asserted-by":"crossref","unstructured":"Mandl LA, Sasaki M, Yang J, Choi S, Cummings K, Goodman SM. Incidence and risk of severe ileus after orthopedic surgery: a case-control study. HSS J. 2020;16:272\u20139.","DOI":"10.1007\/s11420-019-09712-z"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_015","doi-asserted-by":"crossref","unstructured":"Merkow RP, Ju MH, Chung JW, Hall BL, Cohen ME, Williams MV, et al. Underlying reasons associated with hospital readmission following surgery in the United States. JAMA. 2015;313:483\u201395.","DOI":"10.1001\/jama.2014.18614"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_016","doi-asserted-by":"crossref","unstructured":"Booysen V, Burger JR, du Plessis JM, Cockeran M. Assessment of post-operative pain medication adherence after day case orthopaedic surgery: a prospective, cross-sectional study. Int J Orthop Trauma Nurs. 2020;36:100718. 10.1016\/j.ijotn.2019.100718.","DOI":"10.1016\/j.ijotn.2019.100718"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_017","doi-asserted-by":"crossref","unstructured":"Abou Taam M, de Boissieu P, Abou Taam R, Breton A, Trenque T. Drug-induced hallucination: a case\/non case study in the French Pharmacovigilance Database. Eur J Psychiatry. 2015;29:21\u201331","DOI":"10.4321\/S0213-61632015000100002"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_018","doi-asserted-by":"crossref","unstructured":"Sivanesan E, Gitlin MC, Candiotti KA. Opioid-induced Hallucinations: A review of the literature, pathophysiology, diagnosis, and treatment. Anesth Analg. 2016;123:836-43.","DOI":"10.1213\/ANE.0000000000001417"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_019","doi-asserted-by":"crossref","unstructured":"Kalso E and Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharm Ther 1990;47: 639\u201346.","DOI":"10.1038\/clpt.1990.85"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_020","doi-asserted-by":"crossref","unstructured":"Chowdhury MM and Board R. Morphine-induced hallucinations - resolution with switching to oxycodone: a case report and review of the literature. Cases J. 2009;2:9391. 10.1186\/1757-1626-2-9391.","DOI":"10.1186\/1757-1626-2-9391"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_021","doi-asserted-by":"crossref","unstructured":"Maddocks I, Somogyi A, Abbott F, Hayball P, Parker D. Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone. J Pain Symptom Manage. 1996;12:182\u20139.","DOI":"10.1016\/0885-3924(96)00050-4"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_022","doi-asserted-by":"crossref","unstructured":"Gray K, Adhikary SD, Janicki P. Pharmacogenomics of analgesics in anesthesia practice: A current update of literature. J Anaesthesiol Clin Pharmacol. 2018;34:155-60.","DOI":"10.4103\/joacp.JOACP_319_17"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_023","doi-asserted-by":"crossref","unstructured":"Pietarinen P, Tornio A, Niemi M. High frequency of CYP2D6 Ultrarapid Metabolizer Genotype in the Finnish Population. Basic Clin Pharmacol Toxicol. 2016;119:291\u20136.","DOI":"10.1111\/bcpt.12590"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_024","doi-asserted-by":"crossref","unstructured":"H\u00e4kkinen M, Vuori E, Ojanper\u00e4 I. Prescription opioid abuse based on representative postmortem toxicology. Forensic Sci Int. 2014;245:121\u20135.","DOI":"10.1016\/j.forsciint.2014.10.028"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_025","doi-asserted-by":"crossref","unstructured":"Keto J, Heiskanen T, Hamunen K, Kalliom\u00e4ki ML, Linna M. Opioid trends in Finland: a register-based nationwide follow-up study. Sci Rep. 2022;12: 7261. 10.1038\/s41598-022-10788-7.","DOI":"10.1038\/s41598-022-10788-7"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_026","doi-asserted-by":"crossref","unstructured":"Ahom\u00e4ki I, Pitk\u00e4nen V, Soppi A, Saastamoinen L. Impact of a physician- targeted letter on opioid prescribing. J Health Econ. 2020;72:102344. 10.1016\/j.jhealeco.2020.102344.","DOI":"10.1016\/j.jhealeco.2020.102344"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_027","doi-asserted-by":"crossref","unstructured":"Meissner W, Leyendecker P, Mueller-Lissner S, Nadstawek J, Hopp M, Ruckes C, et al. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain. 2009;13:56\u201364.","DOI":"10.1016\/j.ejpain.2008.06.012"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_028","doi-asserted-by":"crossref","unstructured":"Colucci SV, Perrino PJ, Shram M, Bartlett C, Wang Y, Harris SC. Abuse potential of intravenous oxycodone\/naloxone solution in nondependent recreational drug users. Clin Drug Investig. 2014;34:421\u20139.","DOI":"10.1007\/s40261-014-0192-3"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_029","unstructured":"WHO. Adherence to long term therapies: evidence for actions. Geneva, Switzerland: World Health Organization; 2003."},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_030","doi-asserted-by":"crossref","unstructured":"Vetter TR, Downing ME, Vanlandingham SC, Noles KM, Boudreaux AM. Predictors of patient medication compliance on the day of surgery and the effects of providing patients with standardized yet simplified medication instructions. Anesthesiology. 2014;121:29\u201335.","DOI":"10.1097\/ALN.0000000000000175"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_031","unstructured":"Pfeifer K, Slawski B, Manley AM, Nelson V, Haines M. Improving preoperative medication compliance with standardized instructions. Minerva Anestesiol. 2016;82:44\u20139."},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_032","doi-asserted-by":"crossref","unstructured":"Mendes Porto T, Caferatti Machado D, Olivio Martins R, Galato D, Piovezan AP. Locus of pain control associated with medication adherence behaviors among patients after an orthopedic procedure. Patient Prefer Adherence. 2014;8:991\u20135.","DOI":"10.2147\/PPA.S62652"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_033","doi-asserted-by":"crossref","unstructured":"Stessel B, Theunissen M, Marcus MA, Joosten EA, van Kuijk SMJ, Fiddelers AAA, et al. Prevalence and predictors of patient nonadherence to pharmacological acute pain therapy at home after day surgery: a prospective cohort study. Pain Pract. 2018;18:194\u2013204.","DOI":"10.1111\/papr.12589"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_034","doi-asserted-by":"crossref","unstructured":"Callebaut I, Jorissen S, Pelckmans C, Berends N, Droogmans M, van Rossum M, et al. Four-week pain profile and patient non-adherence to pharmacological pain therapy after day surgery. Anesth Pain Med. 2020;10:e101669. 10.5812\/aapm.101669.","DOI":"10.5812\/aapm.101669"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_035","doi-asserted-by":"crossref","unstructured":"Arwi GA, Tuffin PHR, Schug SA. Evaluating adherence of evidence-based post-operative discharge opioid prescribing guidelines and patient outcomes two weeks post-discharge. J Pain Res. 2022;15:3115\u201325.","DOI":"10.2147\/JPR.S345241"},{"key":"2025120910063046202_j_sjpain-2023-0133_ref_036","doi-asserted-by":"crossref","unstructured":"Kelly K, Grau-Sepulveda MV, Goldstein BA, Spratt SE, Wolfley A, Hatfield V, et al. The agreement of patient-reported versus observed medication adherence in type 2 diabetes mellitus (T2DM). BMJ Open Diabetes Res Care. 2016;4:e000182. 10.1136\/bmjdrc-2015-000182.","DOI":"10.1136\/bmjdrc-2015-000182"}],"container-title":["Scandinavian Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/sjpain-2023-0133\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/sjpain-2023-0133\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T13:02:46Z","timestamp":1765285366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/sjpain-2023-0133\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3,7]]},"published-print":{"date-parts":[[2024,3,7]]}},"alternative-id":["10.1515\/sjpain-2023-0133"],"URL":"https:\/\/doi.org\/10.1515\/sjpain-2023-0133","relation":{},"ISSN":["1877-8879"],"issn-type":[{"value":"1877-8879","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,1]]},"article-number":"20230133"}}